Aberdeen Group’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-2,146,329
| Closed | -$11.6M | – | 931 |
|
2020
Q1 | $11.6M | Sell |
2,146,329
-78,331
| -4% | -$423K | 0.04% | 368 |
|
2019
Q4 | $20.1M | Buy |
2,224,660
+159
| +0% | +$1.44K | 0.05% | 328 |
|
2019
Q3 | $16M | Buy |
2,224,501
+32,429
| +1% | +$233K | 0.04% | 360 |
|
2019
Q2 | $17.4M | Buy |
2,192,072
+10,821
| +0.5% | +$86K | 0.04% | 387 |
|
2019
Q1 | $27.4M | Buy |
2,181,251
+75,483
| +4% | +$949K | 0.06% | 294 |
|
2018
Q4 | $40.9M | Buy |
2,105,768
+234,225
| +13% | +$4.55M | 0.1% | 185 |
|
2018
Q3 | $53.1M | Buy |
1,871,543
+401,893
| +27% | +$11.4M | 0.1% | 192 |
|
2018
Q2 | $31M | Buy |
1,469,650
+360,206
| +32% | +$7.59M | 0.06% | 297 |
|
2018
Q1 | $15.8M | Buy |
1,109,444
+23,876
| +2% | +$340K | 0.03% | 386 |
|
2017
Q4 | $13.4M | Buy |
+1,085,568
| New | +$13.4M | 0.03% | 420 |
|